The Effective Management of Ascites and Hepatorenal Syndrome
Hepatorenal syndrome is one of many potential causes of acute kidney injury in patients with liver disease. HRS represents the end-stage of a sequence of reductions in kidney perfusion induced by increasingly severe hepatic injury. HRS is a diagnosis of exclusion and generally has a poor prognosis. A cirrhotic liver disrupts fluid management. Decreased liver function combines with portal hypertension to cause ascites symptoms. Portal hypertension causes fluid to leak from the veins into the belly and collect there. To manage the ascites, patients need to have large volumes of fluid removed or put other organs at risk. Regrettably, not enough clinicians have an adequate understanding of the disease progression, appropriate diagnostic tests and appropriate treatment regimes. This short, but highly focused, seminar will provide that information.
Topics to be covered in this interactive seminar include:
The causes, symptoms, and treatment for ascites
Life-threatening dangers of cirrhosis and the importance of fluid management
Employing realistic sodium reduction approaches for patients with mild ascites
The benefits vs risks of a TIPS procedure
Differentiate between Type 1 and Type 2 HRS
How Hepatorenal Syndrome advances and can lead to renal failure
Investigate the benefits and risks of various HRS treatment approaches
Advising patients on the most efficacious therapies for Hepatorenal Syndrome to minimize further damage to the liver and kidneys
Dates and LocationsApril 7, 2023 – New York, NY
12:00pm – 1:00pm
Hosted by NYU Langone School of Medicine
May 3, 2023 – Orlando, FL
6:30pm – 8:00pm
Hosted by the Florida Association of Physician Assistants
(Offered in conjunction with the Hepatorenal Syndrome seminar)
A web-based, self-paced version of this seminar is also available. Go to the Registration/Information button, then scroll to the bottom of the page to register for the Enduring Material.
CDC-Recommended COVID-19 Precautions will be Implemented at All Live Seminars
Registration Fees: There is no charge for either the live or web-based seminars, but pre-registration is required.
This program has been developed for:
Advanced-Practice Providers and Nurse Specialists
Physicians (MD/DO)- The University of Louisville Office of Continuing Medical Education & Professional Development designates Symptoms and Care Options of IBS as a live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses- The Symptoms and Care Options of IBS seminar has been approved for 1.2 Continuing Education Credits through the University of Louisville Hospital, provider number 4-0068-7-22-1253.
AANP accepts Category I credit from AMA PRA Category 1 Credit(s)™ organizations accredited by ACCME.
AAPA accepts Category I credit from AMA PRA Category 1 Credit(s)™ organizations accredited by ACCME.
Go to the Registration/Information button, then scroll to the bottom of the page to register for the Enduring Material.
This course is supported in part by educational grants from Mallinckrodt Pharmaceuticals, Ironwood Pharmaceuticals and Grifols, USA in accordance with ACCME accreditation Standards of Commercial Support.
For Course or Content Information, please contact SCLRC at email@example.com or at (253) 432-4023
University of Louisville Office of CME and Professional Development
501 E. Broadway Su 370
Louisville, KY 40202
Phone: (502) 852-5329